Nomogram for Predicting Overall Survival and Salvage Abdominoperineal Resection for Patients with Anal Cancer

被引：0

作者：

Tsikitis, Vassiliki L. ^{[1
]}

Lu, Kim C. ^{[1
]}

Kim, Jong S. ^{[2
]}

Billingsley, Kevin G. ^{[3
]}

Thomas, Charles R., Jr. ^{[4
]}

Herzig, Daniel O. ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97239 USA

[2] Portland State Univ, Fariborz Maseeh Dept Math & Stat, Portland, OR 97207 USA

[3] Oregon Hlth & Sci Univ, Dept Surg Oncol, Portland, OR 97239 USA

[4] Oregon Hlth & Sci Univ, Dept Radiat Oncol, Portland, OR 97239 USA

来源：

DISEASES OF THE COLON & RECTUM | 2016年 / 59卷 / 01期

关键词：

10-YEAR PROBABILITY; COLOSTOMY RATES; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY; RECURRENCE;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1 / 7

页数：7

共 20 条

[1] Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression [J].

Alfa-Wali, M. ;

Allen-Mersh, T. ;

Antoniou, A. ;

Tait, D. ;

Newsom-Davis, T. ;

Gazzard, B. ;

Nelson, M. ;

Bower, M. .

ANNALS OF ONCOLOGY, 2012, 23 (01) :141-U473

[2]

[Anonymous], COC ACCR CAT

[3]

[Anonymous], CANC FACTS FIG 2012

[4]

[Anonymous], NAT CANC DAT BAS

[5]

[Anonymous], 2007, ASCRS TXB COLON RECT

[6] Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas [J].

Brennan, MF ;

Kattan, MW ;

Klimstra, D ;

Conlon, K .

ANNALS OF SURGERY, 2004, 240 (02) :293-298

[7] Anal Carcinoma [J].

Engstrom, Paul F. ;

Arnoletti, Juan Pablo ;

Benson, Al B., III ;

Berlin, Jordan D. ;

Berry, J. Michael ;

Chen, Yi-Jen ;

Choti, Michael A. ;

Cooper, Harry S. ;

Dilawari, Raza A. ;

Early, Dayna S. ;

Enzinger, Peter C. ;

Fakih, Marwan G. ;

Fleshman, James, Jr. ;

Fuchs, Charles ;

Grem, Jean L. ;

Knol, James A. ;

Leong, Lucille A. ;

Lin, Edward ;

Mulcahy, Mary F. ;

Rohren, Eric ;

Ryan, David P. ;

Saltz, Leonard ;

Shibata, David ;

Skibber, John M. ;

Small, William, Jr. ;

Sofocleous, Constantinos ;

Thomas, James ;

Venook, Alan P. ;

Willett, Christopher .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (01) :106-120

[8] Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial [J].

Glynne-Jones, R. ;

Kadalayil, L. ;

Meadows, H. M. ;

Cunningham, D. ;

Samuel, L. ;

Geh, J. I. ;

Lowdell, C. ;

James, R. ;

Beare, S. ;

Begum, R. ;

Ledermann, J. A. ;

Sebag-Montefiore, D. .

ANNALS OF ONCOLOGY, 2014, 25 (08) :1616-1622

[9] Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Glynne-Jones, R. ;

Northover, J. M. A. ;

Cervantes, A. .

ANNALS OF ONCOLOGY, 2010, 21 :v87-v92

[10] Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin [J].

Gunderson, Leonard L. ;

Winter, Kathryn A. ;

Ajani, Jaffer A. ;

Pedersen, John E. ;

Moughan, Jennifer ;

Benson, Al B., III ;

Thomas, Charles R., Jr. ;

Mayer, Robert J. ;

Haddock, Michael G. ;

Rich, Tyvin A. ;

Willett, Christopher G. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4344-4351

← 1 2 →